TMEDvsIHEETF Comparison
T. Rowe Price Health Care ETF (TMED) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. TMED's top 3 sector exposures are Health Care and Financials. In contrast, IHE's top sector exposures are Health Care TMED is more expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.38% for IHE. TMED is up 2.73% year-to-date (YTD) with +$3M in YTD flows. IHE performs worse with 1.79% YTD performance, and +$81M in YTD flows. Run a side-by-side ETF comparison of TMED and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
TMED vs IHE performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TMED IHE | +8.31%+2.19% | -1.96%-0.54% | +2.73%+1.79% | n/a+32.62% | n/a+49.10% | n/a+55.06% |
| Flows | TMED IHE | -$41K-$48M | +$3M-$25M | +$3M+$81M | -+$205M | -+$312M | -+$345M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TMED IHE | +21.15%+18.50% | n/a+17.94% | n/a+16.14% | n/a+15.99% |
| Max drawdown | TMED IHE | -11.09%-8.48% | n/a-9.18% | n/a-16.04% | n/a-16.12% |
| Max drawdown duration | TMED IHE | 90d54d | n/a82d | n/a210d | n/a669d |
TMED | IHE | |
Last sale 4/24/2026 at 1:30 PM | $29.79 | $86.02 |
| Previous close 04/23/2026 | $30.13 | $86.87 |
| Consolidated volume 04/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
TMED | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
TMED | IHE | |
|---|---|---|
| Last price | $29.79 | $86.02 |
| 1D performance | -1.14% | -0.98% |
| AuM | $19.82 M | $941.80 M |
| E/R | 0.44% | 0.38% |
TMED | IHE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | iShares |
| Benchmark | - | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 76 | 45 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2025 | May 1, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
